Investigation on the Effect of Smoking on the Expression of Pro- and Anti-thrombotic, Anti-oxidative, and Inflammatory Markers in Humans

Terminated

• Conditions: Smoking; Inflammation; Thrombosis
• Interventions: Other: Blood sample

• Registration Number: NCT02198937
• Lead Sponsor: University of Zurich

Brief Summary

Investigation on the effect of smoking on thrombus formation in humans. The expression of pro- and anti-thrombotic, anti-oxidative, and inflammatory markers will be assessed in 25-50 year old healthy smokers and non-smokers. The investigators are interested in possible differences between the two groups.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2014-06
• Study First Submitted: 2014-07-21
• Study First Submitted QC: 2014-07-23
• Study First Posted: 2014-07-24
• Primary Completion: 2016-03
• Study Completion: 2016-03
• Status Verified: 2016-10
• Last Update Submitted: 2016-10-24
• Last Update Posted: 2016-10-25

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

• Smoker
• Non-smokers

Read More

Exclusion Criteria

• Disease
• Pregnancy

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Non-Smokers	Blood sample	Healthy non-smokers
Smokers	Blood sample	Healthy smokers

Primary Outcome Measures

Name	Time	Method
Expression of pro- and anti-thrombotic, anti-oxidative, and inflammatory markers in blood	Single time point, no follow-up (cross sectional)

Trial Locations

Locations (1)

University Hospital; 🇨🇭 Zurich, Switzerland